Skip to content
The Nexus
DossierENTITY

Clesrovimab

Coverage of Clesrovimab in the Nexus archive.

Earliest in view: Jul 20 · 18:45 UTCMost recent: Jul 20 · 18:45 UTC
Co-mentioned in this coverage
Enflonsiatopic1Respiratory Syncytial Virustopic1MedPage Todayorganization1infants at increased risk for severe diseasetopic1randomized clinical trialtopic1
Recent coverage
  • HEALTHJul 20 · 18:45 UTCMEDPAGE TODAY
    Second Season of Clesrovimab for RSV Well Tolerated in High-Risk Kids

    The long-acting monoclonal antibody clesrovimab (Enflonsia) was well tolerated in high-risk infants during two RSV seasons, according to a randomized clinical trial. The drug is used for RSV prevention in infants at increased risk for severe disease.

Clesrovimab · Dossier · The Nexus